Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 9891-9898

  Chinsangaram, Jarasvech ^a   Piccone, Maria E ^a,b   Grubman, Marvin J ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ANIMAL CELL; ARTICLE; CELL CULTURE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0032731093     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.9891-9898.1999     Document Type: Article

References (32)

1. Bachrach, H. L. 1978. Foot-and-mouth disease: world-wide impact and control measures, p. 299-310. In E. Kurstak and K. Maramorosch (ed.), Viruses and environment. Academic Press, Inc., New York, N.Y.
2. Beck, E., and K. Strohmaier. 1987. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61: 1621-1629.
3. r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J. Virol. 63:2244-2251.
4. Brown, C. C., M. E. Piccone, P. W. Mason, T. S.-C. McKenna, and M. J. Grubman. 1996. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in bovines. J. Virol. 70:5638-5641.
5. Brown, F. 1992. New approaches to vaccination against foot-and-mouth disease. Vaccine 10:1022-1026.
6. Chinsangaram, J., P. W. Mason, and M. J. Grubman. 1998. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16:1516-1522.
7. Degen, J. L., M. G. Neubauer, S. J. Freizner-Degen, C. E. Seyfried, and D. R. Morris. 1983. Regulation of protein synthesis in mitogen-activated bovine lymphocytes. Analysis of actin-specific and total mRNA accumulation and utilization. J. Biol. Chem. 258:12153-12162.
8. DeStefano, J., E. Olmstead. R. Panniers, J. Lucas-Lenard. 1990. The a subunit of eucaryotic initiation factor 2 is phosphorylated in mengovirus-infected mouse L cells. J. Virol. 64:4445-4453.
9. Devaney, M. A., V. N. Vakharia, R. E. Lloyd, E. Ehrenfeld, and M. J. Grubman. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62:4407-4409.
10. Gorbalenya, A. E., E. V. Koonin, and M. M.-C. Lai. 1991. Putative papain-related thiol proteases of positive-strand RNA viruses: identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, α-, and coronaviruses. FEBS Lett. 288:201-205.
11. Gresser, I., M.-T. Bandu, D. Brouty-Boye, and M. Tovey. 1974. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature 251:543-545.
12. House, C., and J. A. House. 1989. Evaluation of techniques to demonstrate foot-and-mouth disease virus in bovine tongue epithelium: comparison of the sensitivity of cattle, mice, primary cell cultures, cryopreserved cell cultures and established cell lines. Vet. Microbiol. 20:99-109.
13. King, A. M. Q., B. O. Underwood, D. McCahon, J. W. I. Newman, and F. Brown. 1981. Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK. Nature 293:479-480.
14. Kirchweger, R., E. Ziegler, B. J. Lamphear, D. Waters, H.-D. Liebig, W. Sommergruber, F. Sobrino, C. Hohenadl, D. Blass, R. E. Rhoads, and T. Skern. 1994. Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4γ. J. Virol. 68:5677-5684.
15. Kleina, L. G., and M. J. Grubman. 1992. Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J. Virol. 66:7168-7175.
16. Marie, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
17. Mason, P. W., M. E. Piccone, T. S.-C. McKenna, J. Chinsangaram, and M. J. Grubman. 1997. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96-102.
18. McCauley, E. H., N. A. Aulaqi, J. C. New, W. B. Sundquist, and W. M. Miller. 1979. A study of the potential economic impact of foot-and-mouth disease in the United States. U.S. Government Printing Office, Washington, D.C.
19. Medina, M., E. Domingo, J. K. Brangwyn, and G. J. Belsham. 1993. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194:355-359.
20. Muller, U., U. Steinhoff, L. F. L. Resi, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
21. pro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2. J. Virol. 63:5069-5075.
22. Piccone, M. E., E. Rieder, P. W. Mason, and M. J. Grubman. 1995. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69:5376-5382.
23. Piccone, M. E., M. Zellner, T. F. Kumosinski, P. W. Mason, and M. J. Grubman. 1995. Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J. Virol. 69:4950-4956.
24. Rieder, E., T. Bunch, F. Brown, and P. W. Mason. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:5139-5145.
25. Roberts, P. J., and G. J. Belsham. 1995. Identification of the critical amino acids within the foot-and-mouth disease virus leader protein, a cysteine protease. Virology 213:140-146.
26. Rueckert, R. R. 1996. Picornaviridae: the viruses and their replication, p. 609-654. In B. N. Fields, D. M. Knipe, and P. H. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
27. Salt, J. S. 1993. The carrier state in foot-and-mouth disease virus - an immunologicai review. Br. Vet. J. 149:207-223.
28. Sellers, R. F. 1963. Multiplication, interferon production and sensitivity of virulent and attenuated strains of the virus of foot-and-mouth disease. Nature (London) 198:1228-1229.
29. Sellers, R. F. 1964. Virulence and interferon production of strains of foot-and-mouth disease virus. J. Immunol 93:6-12.
30. Sellers, R. F., J. H. Bennett, G. N. Mowat, and W. A. Snowdon. 1968. Some factors affecting interferon production by foot-and-mouth disease virus in bovine tissue cultures. Arch. Gesamte Virusforsch. 23:1-11.
31. Strebel, K., and E. Beck. 1986. A second protease of foot-and-mouth disease virus. J. Virol. 58:893-899.
32. Vilcek, J., and G. C. Sen. 1996. Interferons and other cytokines, p. 375-399. In B. N. Fields, D. M. Knipe, and P. H. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.